Seaport Therapeutics, Inc. (SPTX)

NASDAQ: SPTX · Real-Time Price · USD

17.00

-2.84 (-14.31%)

At close: May 4, 2026, 4:00 PM EDT

17.59

+0.59 (3.44%)

After-hours: May 4, 2026, 7:47 PM EDT

Seaport Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	20.98	27.35
Research & Development	64.42	25.07
Operating Expenses	85.4	52.42
Operating Income	-85.4	-52.42
Interest & Investment Income	11.4	5.54
Other Non Operating Income (Expenses)	-3.55	-
EBT Excluding Unusual Items	-77.54	-46.88
Gain (Loss) on Sale of Investments	3.43	-
Pretax Income	-74.11	-46.88
Income Tax Expense	0.77	-
Net Income	-74.88	-46.88
Net Income to Common	-74.88	-46.88
Shares Outstanding (Basic)	7	3
Shares Outstanding (Diluted)	7	3
Shares Change (YoY)	151.76%	-
EPS (Basic)	-10.04	-15.83
EPS (Diluted)	-10.04	-15.83
Free Cash Flow	-78.3	-29.74
Free Cash Flow Per Share	-10.50	-10.04
EBITDA	-85.22	-52.25
D&A For EBITDA	0.17	0.17
EBIT	-85.4	-52.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q